In The News - Technology

In The News - Technology

Wyss Institute
December 5, 2018 Project combines highly sensitive biomarker discovery with human stem cell technology to develop a much needed blood diagnostic assay for Parkinson’s disease By Benjamin Boettner
PharmaVOICE | November 16, 2018
Contributed by: Denise Myshko
Forbes | September 22, 2018
By Tom Taulli | Contributor
September 25, 2018
In a recent interview with Baystate Business, Kevin Hrusovsky, Quanterix Chairman and CEO and founder of Powering Precision Health, explains the fundamentals of Quanterix technology and how it's disrupting the way healthcare is practiced.  Click the file below to hear the interview.
Digital Biotech | September 07, 2018
Kevin Hrusovsky, Quanterix Chairman and CEO and Founder of Powering Precision Health, recently sat down with TetraScience CEO Alok Tayi to talk about the exciting work that Quanterix is doing in the area of clinical biomarkers and the business of diagnostics, as well as healthcare, more broadly,
SelectScience Interview | January 29, 2018
Ralph McDade explains the importance of using ultra-sensitive immunoassays from Quanterix
SelectScience Interview | January 29, 2018
Henrik Zetterberg discusses the use of ultrasensitive biomarker assays from Quanterix for Alzheimer’s research
CLP Magazine | September 26, 2017
Quanterix Corp, Lexington, Mass, is expanding its single molecule array, or Simoa, portfolio to include the new Quanterix SR-Plex benchtop instrument.
Biocompare | September 19, 2017
Tracking multiple targets in one reaction is an increasing requirement of assays being used in molecular biology and medicine.